Table 3.
Total | Dead | Outcome 3c | Univariate Cox regressiond | Multivariable Cox regressiond | ||
---|---|---|---|---|---|---|
n | n | % | HR (95%CI) | aHR (95%CI) | ||
Age category | 15–24 years | 279,452 | 13,922 | 5.0 | Reference | Reference |
25–34 years | 644,837 | 55,122 | 8.5 | 1.73 (1.7–1.76) | 1.42 (1.4–1.45) | |
35–44 years | 584,348 | 59,160 | 10.1 | 2.06 (2.02–2.09) | 1.66 (1.63–1.69) | |
45–54 years | 354,032 | 41,649 | 11.8 | 2.41 (2.37–2.46) | 2.11 (2.07–2.15) | |
55–64 years | 167,905 | 25,480 | 15.2 | 3.19 (3.13–3.26) | 3.15 (3.09–3.22) | |
65+ years | 91,845 | 19,053 | 20.7 | 4.54 (4.44–4.64) | 5.22 (5.1–5.33) | |
Sex | Male | 1,172,409 | 121,491 | 10.4 | Reference | Reference |
Female | 950,010 | 92,895 | 9.8 | 0.94 (0.93–0.95) | 0.95 (0.94–0.95) | |
HIV status | HIV-negative | 607,943 | 37,971 | 6.2 | Reference | Reference |
HIV unknown | 308,414 | 40,629 | 13.2 | 2.14 (2.11–2.17) | 2.17 (2.13–2.2) | |
HIV-positive not on ART | 419,369 | 59,755 | 14.2 | 2.32 (2.3–2.35) | 2.66 (2.62–2.69) | |
HIV-positive on ART | 786,693 | 76,031 | 9.7 | 1.55 (1.53–1.57) | 1.86 (1.83–1.88) | |
Previous TB treatment | New | 1,839,987 | 176,943 | 9.6 | Reference | Reference |
Retreatment | 282,432 | 37,443 | 13.3 | 1.3 (1.29–1.32) | 1.27 (1.26–1.29) | |
Site of disease | PTB | 1,861,447 | 177,375 | 9.5 | Reference | reference |
EPTB | 260,972 | 37,011 | 14.2 | 1.43 (1.42–1.45) | 1.41 (1.39–1.42) | |
Disseminated TBa,b | Not disseminated | 1,913,826 | 183,896 | 9.6 | Reference | |
Disseminated | 62,196 | 12,556 | 20.2 | 2.05 (2.02–2.09) | ||
Year of TB treatment | 2009 | 291,600 | 36,594 | 12.5 | Reference | Reference |
2010 | 285,348 | 33,838 | 11.9 | 0.94 (0.93–0.96) | 0.97 (0.96–0.99) | |
2011 | 292,643 | 32,185 | 11.0 | 0.87 (0.86–0.88) | 0.93 (0.92–0.95) | |
2012 | 271,845 | 28,754 | 10.6 | 0.84 (0.83–0.85) | 0.96 (0.94–0.97) | |
2013 | 262,554 | 24,402 | 9.3 | 0.75 (0.74–0.76) | 0.92 (0.91–0.94) | |
2014 | 251,812 | 21,527 | 8.5 | 0.7 (0.69–0.71) | 0.89 (0.88–0.91) | |
2015 | 246,557 | 20,018 | 8.1 | 0.66 (0.64–0.67) | 0.85 (0.84–0.87) | |
2016 | 220,060 | 17,068 | 7.8 | 0.63 (0.61–0.64) | 0.81 (0.8–0.83) |
ART: antiretroviral therapy; EPTB: extrapulmonary TB; ICD10: International classification of disease 10; PTB: pulmonary TB; TB: tuberculosis.
p-values not shown, all p-values in multi variable model significant < 0.0001.
aDisseminated TB not added to final model due to collinearity with site of TB disease.
bDisseminated TB included 146,397 with unknown classification due to missing ICD10 codes.
cOutcome 3: calculated as percentage of deaths among those with known outcomes where person time on treatment was documented.
dCox regression models restricted to individuals with known final vitality status. Unknown outcomes (lost to follow up, moved or not evaluated) n = 409,114 excluded.